ABBVIE INC.

ABBV
Real-time Estimate Quote. Real-time Estimate  - 10/22 05:28:57 pm
84.475USD +1.91%
Prev.82.8900
Open83.0200
High84.8900
Low82.9200
Volume9 776 877
Latest news
3d ago
3d ago
3d ago
3d ago
Chart ABBVIE INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBullish
Resistance86,3101101
Spread/Res.-2,3%-16%-16%
Spread/Supp.1,7%3,0%1,8%
Support82,981,982,8
Financials
Sales 2020 45 364 M - -
Net income 2020 10 285 M - -
Net Debt 2020 73 871 M - -
P/E ratio 2020 15,7x
Yield 2020 5,96%
Capitalization 149 B 149 B -
EV / Sales 2020 4,91x
EV / Sales 2021 3,97x
Nbr of Employees 47 000
Free-Float 98,5%
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2020-10-30 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 19
Average target price 109,21 $
Last Close Price 82,89 $
Spread / Highest target 53,2%
Spread / Average Target 31,8%
Spread / Lowest Target 15,8%